drugset / Trial / NCT02351622
Caffeic Acid Tablets as a Second-line Therapy for ITP
Phase 3
Completed
103 enrolled
Shandong University
Anhui Medical University · collabQianfoshan Hospital · collabQingdao University · collabShandong Provincial Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The investigators are undertaking a multicentre, randomised controlled trial of 120 adults with newly diagnosed ITP from 5 medical centers in China. Part of the participants are randomly selected to receive caffeic acid tablets combining dexamethasone and the other part are selected to receive high-dose dexamethasone treatment. Platelet count, bleeding and other symptoms were evaluated before and after treatment. Adverse events are also recorded throughout the study.
Timeline
- Start
- 2012-09
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caffeic acid | Small molecule | 0.3 g | Oral |
| Background | Dexamethasone | Small molecule | 40 mg | Oral |